The glucagon-like peptide 1 receptor agonist liraglutide attenuates placental ischemia-induced hypertension - Younes, Subhi Talal; Maeda, Kenji J.; Sasser, Jennifer; Ryan, Michael J. (American journal of physiology. Heart and circulatory physiology, 2020)
Keywords: Agonists; Animals; Animals, Newborn; Antidiabetics; Antihypertensive Agents - pharmacology; Antihypertensive Agents - toxicity; Appetite Regulation - drug effects; Birth Weight - drug effects; Blood pressure; Blood Pressure - drug effects; Diabetes mellitus; Disease Models, Animal; Female; Food intake; GLP-1 receptor agonists; Glucagon; Glucagon-like peptide 1; Glucagon-Like Peptide-1 Receptor - agonists; Glucagon-Like Peptide-1 Receptor - metabolism; Hypertension; Ischemia; Ischemia - complications; Ischemia - drug therapy; Ischemia - metabolism; Ischemia - physiopathology; Liraglutide - pharmacology; Liraglutide - toxicity; Nitric oxide; Nitric Oxide - metabolism; Nitric Oxide Synthase Type III - metabolism; Nitric-oxide synthase; NOS3 protein; Peptides; Perfusion; Placenta; Placenta - blood supply; Pre-eclampsia; Pre-Eclampsia - etiology; Pre-Eclampsia - metabolism; Pre-Eclampsia - physiopathology; Pre-Eclampsia - prevention & control; Preeclampsia; Pregnancy; Rats; Regional Blood Flow; Renal function; Signal Transduction; Uterus; nitric oxide; GLP-1; preeclampsia; pregnancy